Monitor upcoming earnings and pipeline updates closely — coordinated C-suite selling, especially by the CEO, often precedes downward revisions or clinical setbacks. Consider this a warning sign despite recent analyst optimism.
Price Chart
Executive Summary
Five executives at Travere Therapeutics, including the CEO, CFO, and CMO, sold shares in a coordinated cluster totaling $2.99M over a 7-day period, with the CEO accounting for $2.33M of the total. This represents a significant insider selling event involving key C-suite leaders, suggesting potential lack of confidence in near-term prospects despite no disclosed fundamental changes.
Key Financial Metrics
Key Facts
- Five insiders sold a total of $2.99M in shares over 7 days
- CEO Dube Eric M. sold 56.8K shares for $2.33M, representing 78% of total cluster value
- All transactions were open-market sales (code S), not related to grants or tax events
- Sales occurred at prices between $39.09 and $42.61 per share
- Total cluster value represents ~0.08% of $3.7B market cap — modest in relative terms but highly concentrated among top executives
Financial Impact
$2.99 million in insider selling over 7 days, with $2.33M from the CEO alone
Risk Factors
- Potential for negative clinical or regulatory news in the near term
- Erosion of investor confidence due to concentrated executive selling
- Possible misalignment between management and shareholder interests
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-TVTX-1776974730257 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 9, 2026 12w ago | 8-K | $56.59 $61.32 | ▲ +8.36% | ▲ +5.93% | $56.93 (+0.60%) |
Jun 16, 2026 15w ago | Insider Cluster | $54.14 $55.28 | ▲ +2.11% | ▲ +0.79% | $56.93 (+5.15%) |
Jun 16, 2026 15w ago | 8-K | $54.14 $55.28 | ▲ +2.11% | ▲ +0.79% | $56.93 (+5.15%) |
Jun 12, 2026 16w ago | 144 | $52.04 $56.59 | ▲ +8.74% | ▲ +6.96% | $56.93 (+9.40%) |
Jun 2, 2026 17w ago | 8-K | $42.96 $56.34 | ▲ +31.15% | ▲ +32.71% | $56.93 (+32.52%) |
May 15, 2026 20w ago | 144 | $42.59 $53.80 | ▲ +26.32% | ▲ +24.20% | $56.93 (+33.67%) |
May 5, 2026 21w ago | 144 | $44.76 $45.20 | ▲ +0.98% | ▼ −1.80% | $56.93 (+27.19%) |
May 4, 2026 21w ago | 144 | $44.80 $42.96 | ▼ −4.11% | ▼ −9.06% | $56.93 (+27.08%) |
May 1, 2026 22w ago | Insider Cluster | $44.12 $45.04 | ▼ −2.09% | ▲ +3.20% | $56.93 (−29.03%) |
Apr 15, 2026 24w ago | 144 | $40.95 $42.84 | ▲ +4.62% | ▼ −1.43% | $56.93 (+39.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access